ASX Announcement

David Stamler appointed as CMO to lead Clinical Development

Published: 05/06/17, 10:16am (AEST)2 pages
Alterity Therapeutics Limited
ATH:ASXHealthcare

Recent ATH Announcements

Price Sensitive only